FDA flags more Olympus safety problems in import block and warning letter

The FDA import alert broadens the scope of a 2025 import action covering dozens of endoscopes and comes two weeks after a new warning letter…

New clinical trial backed by Andy Burnham could speed up Alzheimer’s treatments

The Prime Minister’s father Roy died with Alzheimer’s disease in September.

TrivarX Partners with Syntro Health for Stabl-Im Formulation Ahead of 2027 Clinical Trial - Kalkine Media

ChemPharma R&D Summit 2026 to discuss Pharma 2.0: Moving Beyond Generics on October 27

Speakers include Parizad A. Elchidana, ACG World; Dr. Kiran Marthak, Veeda Life Sciences; Dr. Ravikrishna Chebolu, CSIR Innovation Complex; Dr…

FDA Approves PASCAL Precision for Transcatheter Tricuspid Valve Repair

The company also shared that the FDA has approved the PASCAL Ace with Capture Clarity system for use in degenerative mitral TEER procedures (M-TEER).

Second life for pharma’s secret drug discovery data

Qubigen can make use of trial data without moving or copying it, saving other researchers from wild goose chases.

Over 70 Pharma Companies to Participate in Vijayawada Fair

More than 70 pharmaceutical companies will participate in the 17th Indian Pharma Fair in Vijayawada on October 23 and 24, attracting up to 8,000…

FDA recalls GLP-1 drug, other injectable medication over sterility concerns

Apothecary Pharma is recalling 23 vials of compounded injectable drugs distributed nationwide because their sterility cannot be assured, according…

Novartis Pharma AG: Novartis receives European Commission approval for Cosentyx in polymyalgia rheumatica (PMR)

Cosentyx (secukinumab) becomes first and only IL-17A inhibitor approved in Europe for adults with PMR,1 a common inflammatory rheumatic disease with…

STAT+: GSK picks up hep B drug approval

GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous methods.

Argentina eases drug import rules, creating new export avenues for India

The new framework dismantles long-standing regulatory barriers for Indian manufacturers, enabling a direct export of Indian medicines, active…

Okomera Announces a Commercial Agreement With Servier to Use Its Tumor Miniaturization Technology for Cancer Research

PARIS--(BUSINESS WIRE)-- #Okomera--Okomera, a TechBio company pioneering personalized cancer care through a proprietary technology platform…